Henry Schein, Inc. (NASDAQ:HSIC) was the recipient of a significant increase in short interest in the month of March. As of March 29th, there was short interest totalling 19,816,414 shares, an increase of 15.4% from the March 15th total of 17,167,594 shares. Based on an average daily trading volume, of 1,937,250 shares, the days-to-cover ratio is currently 10.2 days. Approximately 13.1% of the shares of the company are short sold.
Several analysts have issued reports on the company. Leerink Swann upgraded Henry Schein from a “market perform” rating to an “outperform” rating and set a $75.00 target price on the stock in a research note on Wednesday, April 4th. BidaskClub upgraded Henry Schein from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 27th. Barclays assumed coverage on Henry Schein in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $71.00 target price on the stock. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Finally, Bank of America assumed coverage on Henry Schein in a research report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target for the company. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and nine have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $82.31.
Shares of NASDAQ HSIC opened at $69.72 on Friday. The firm has a market capitalization of $10,699.56, a PE ratio of 19.37, a P/E/G ratio of 1.70 and a beta of 1.05. Henry Schein has a fifty-two week low of $62.56 and a fifty-two week high of $93.50. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.45 and a quick ratio of 0.76.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.97 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.97. Henry Schein had a return on equity of 19.70% and a net margin of 3.26%. The company had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.30 billion. During the same period in the previous year, the business earned $0.94 earnings per share. The firm’s quarterly revenue was up 6.3% compared to the same quarter last year. equities research analysts predict that Henry Schein will post 4.09 earnings per share for the current year.
A number of institutional investors have recently bought and sold shares of the stock. Xact Kapitalforvaltning AB grew its position in Henry Schein by 16.7% during the fourth quarter. Xact Kapitalforvaltning AB now owns 64,249 shares of the company’s stock worth $4,490,000 after buying an additional 9,191 shares in the last quarter. Envestnet Asset Management Inc. grew its position in Henry Schein by 19.1% during the fourth quarter. Envestnet Asset Management Inc. now owns 51,745 shares of the company’s stock worth $3,617,000 after buying an additional 8,281 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in Henry Schein by 5.2% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 249,817 shares of the company’s stock worth $17,457,000 after buying an additional 12,271 shares in the last quarter. We Are One Seven LLC purchased a new position in Henry Schein during the fourth quarter worth about $289,000. Finally, OLD Mutual Customised Solutions Proprietary Ltd. grew its position in Henry Schein by 38.8% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 11,100 shares of the company’s stock worth $776,000 after buying an additional 3,100 shares in the last quarter. Institutional investors and hedge funds own 98.18% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2018/04/13/henry-schein-inc-hsic-short-interest-up-15-4-in-march.html.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.